Search

everythinglearnresearchcommunity

for

Search:↓

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

Stopping the drug usually helps, but tamoxifen or surgery may be needed if symptoms persist.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Antiandrogen therapy is effective and well tolerated for treating women's androgenic disorders like hirsutism, acne, and hair loss.

Antiandrogens help treat hormone-related conditions in both men and women.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

Diane® is an effective contraceptive that also helps treat acne and mild hair growth issues.